Article
Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression.
Science translational medicine - 31 Mar 2021
Xhonneux Louis-Pascal, Knight Oliver, Lernmark Åke, Bonifacio Ezio, Hagopian William A, Rewers Marian J, She Jin-Xiong, Toppari Jorma, Parikh Hemang, Smith Kenneth G C, Ziegler Anette-G, Akolkar Beena, Krischer Jeffrey P, McKinney Eoin F
Abstract excerpt
Type 1 diabetes (T1D) is a disease of insulin deficiency that results from autoimmune destruction of pancreatic islet β cells. The exact cause of T1D remains unknown, although asymptomatic islet autoimmunity lasting from weeks to years before diagnosis raises the possibility of intervention before the onset of clinical disease. The number, type, and titer of islet autoantibodies are associated with long-term...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
